Modalis Therapeutics Corporation【JP:4883】Cash flow
Market cap
¥4.3B
P/E ratio
| 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Depreciation & amortization | 7 | 58 | 78 | 124 | 1 | - | - |
| Cash from operations | 224 | -377 | -747 | -1,896 | -2,254 | -1,432 | -2,118 |
| Capital expenditures | -54 | -15 | -107 | -197 | -40 | -0 | -3 |
| Cash from investing | -62 | -830 | 172 | -186 | -40 | -0 | -3 |
| Repurchases of common stock | - | - | -0 | - | - | - | - |
| Cash from financing | 2,491 | 2,778 | 73 | 64 | 1,216 | 3,045 | 1,351 |
| Free cash flow | |||||||
| FCF margin (%) | - | - | - |